These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16751654)

  • 41. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
    Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
    J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voriconazole for candidosis: an important addition?
    Graybill JR
    Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
    [No Abstract]   [Full Text] [Related]  

  • 43. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
    Fincher T; Fulcher SF
    Cornea; 2007 Jun; 26(5):618-20. PubMed ID: 17525663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
    Manfredi R; Sabbatani S
    Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
    Cacciapuoti A; Halpern J; Mendrick C; Norris C; Patel R; Loebenberg D
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2587-90. PubMed ID: 16801452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
    Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
    Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Invasive aspergillosis: clinical manifestations and treatment].
    Lumbreras C; Gavaldá J
    Rev Iberoam Micol; 2003 Sep; 20(3):79-89. PubMed ID: 15456363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Invasive multisystemic aspergillosis in an immunocompetent child: case report].
    Donoso F A; Camacho A J; Alarcón L P; Cruces R P
    Rev Chilena Infectol; 2006 Mar; 23(1):69-72. PubMed ID: 16462968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
    Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
    Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
    Gahn B; Schub N; Repp R; Gramatzki M
    Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
    Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
    Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of an Aspergillus brain abscess with caspofungin: case report of a diabetic patient intolerant of amphotericin B.
    Colombo AL; Rosas RC
    Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):575-6. PubMed ID: 12938012
    [No Abstract]   [Full Text] [Related]  

  • 55. Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    Klastersky J
    N Engl J Med; 2004 Sep; 351(14):1445-7. PubMed ID: 15459307
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():89-94. PubMed ID: 15686055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
    Kulemann V; Bauer M; Graninger W; Joukhadar C
    Pharmacology; 2005 Dec; 75(4):165-78. PubMed ID: 16192747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
    Chirch L; Roche P; Fuhrer J
    Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopenia.
    Buchheidt D; Hummel M; Diehl S; Hehlmann R
    Eur J Haematol; 2004 May; 72(5):375-6. PubMed ID: 15059076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.